• E G Votta-Velis, T Piegeler, R D Minshall, J Aguirre, B Beck-Schimmer, D E Schwartz, and A Borgeat.
• Department of Anaesthesiology, University of Illinois at Chicago, Chicago, IL, USA; Jesse Brown VA Medical Center, University of Illinois at Chicago, Chicago, IL, USA.
• Acta Anaesthesiol Scand. 2013 Nov 1; 57 (10): 1211-29.

AbstractClinical and basic science studies have demonstrated the anti-inflammatory properties of local anaesthetics. Recent studies have begun to unravel molecular pathways linking inflammation and cancer. Regional anaesthesia is associated in some retrospective clinical studies with reduced risk of metastasis and increased long-term survival. The potential beneficial effects of regional anaesthesia have been attributed mainly to the inhibition of the neuroendocrine stress response to surgery and to the reduction in the requirements of volatile anaesthetics and opioids. Because cancer is linked to inflammation and local anaesthetics have anti-inflammatory effects, these agents may participate in reducing the risk of metastasis, but their mechanism of action is unknown. We demonstrated in vitro that amide local anaesthetics attenuate tumour cell migration as well as signalling pathways enhancing tumour growth and metastasis. This has provided the first evidence of a molecular mechanism by which regional anaesthesia might inhibit or reduce cancer metastases. © 2013 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

19 keywords...

hide…